Second consensus statement on the use of antimicrobial drugs in chronic obstructive pulmonary disease exacerbations;Segundo documento de consenso sobre uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica

Revista Espanola de Quimioterapia

Volumn 15, Issue 4, 2002, Pages 375-385

  Alvarez F ^b   Bouza, E ^b   Garcia Rodriguez J A ^a   Mensa, J ^b   Monso E ^b   Picazo, J J ^b   Sobradillo, V ^b   Torres, A ^b   Moya Mir, M ^b   Martinez Ortiz de Zarate M ^b   Perez Escanilla F ^b   Puentes, T ^b   Canada J L ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CIPROFLOXACIN; CLARITHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; TELITHROMYCIN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG INDICATION; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; MORAXELLA CATARRHALIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; HOSPITALIZATION; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; VACCINES;

EID: 0842334410     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Snider, G.L., Kleinreman, J., Thurlbeck, W.M., Bengali, Z.H. The definition of emphysema: Report of the National Heart and Blood Institute, division of lung diseases, workshop. Am Rev Respir Dis 1985; 132: 182-185.
2. Frías, J., Gomis, M., Prieto, J. y cols. Tratamiento antibiótico empírico inicial de la neumonía adquirida en la comunidad. Rev Esp Quimioterap 1998; 11: 255-261.
3. Bosanquet, N. Europe and tobacco. BMJ 1992; 304: 370-372.
4. Sobradillo, V., Miratvilles, M., Gabriel, R. y cols. Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC Multicentre Epidemiological Study. Chest 2000; 118: 981-989.
5. Ballester, F., Pérez-Hoyos, S., Rivera, M.L. y cols. Patrones de frecuentación y factores asociados al ingreso en el hospital de las urgencias hospitalarias pot asma y enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 1999; 35: 20-26.
6. Grupo para el Estudio de la Infección en Urgencias. Estudio epidemiológico de las infecciones en el Área de Urgencias. Emergencias 2000; 12: 80-89.
7. Martínez Ortiz de Zárate, M. Aspectos epidemiológicos de las infecciones en las Áreas de Urgencias. Emergencias 2001; 13 (Supl. 2): S44-S50.
8. Vaqué, J., Grupo de Trabajo EPINE. Evolución de la prevalencia de las infecciones nosocomiales en los hospitales españoles. Proyecto EPINE 1990-1997. Sociedad Española de Medicina Preventiva, Salud Pública e Higiene, Madrid 1998.
9. MacFarlane, J.T., Colville, A., Guion, A., MacFarlane, R.M., Rose, D.H. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 1993; 341: 511-514.
10. Woodhead, M., Gialdroni Grassi, G., Huchon, G.J., Léophonte, P., Manresa, F., Schaberg, T. Use of investigations in lower respiratory tract infection in the community: A European survey. Eur Respir J 1996; 9: 1596-1600.
11. Huchon, G., Gialdroni-Grassi, G., Léophonte, P., Manresa, F., Schaberg, T., Woodhead, M. Initial antibiotic therapy for lower respiratory tract infection in the communion: A European survey. Eur Respir J 1996; 9: 1590-1595.
12. Romero Vivas, J., Rubio Alonso, M., Corral, O., Pacheco, S., Agudo, E., Picazo, J.J. Estudio de las infecciones respiratorias extrahospitalarias. Enferm Infecc Microbiol Clin 1997; 15: 289-298.
13. Miravitlles, M., Espinosa, C., Fernández-Laso, E. y cols. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest 1999; 116: 40-46.
14. Eller, J., Ede, A., Schaberg, T., Niederman, M.S., Mauch, H., Lode, H. Infective exacerbations of chronic bronchitis. Relation between bacteriologic etiology and lung function. Chest 1998; 113: 1542-1548.
15. Monsó, E., Ruiz, J., Rosell, A. y cols. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995; 152: 1316-1320.
16. Soler, N., Torres, A., Ewig, S. y cols. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157: 1498-1505.
17. Xu, X., Wang, L. Association of indoor and outdoor particulate pollution level with chronic respiratory illness. Am Rev Respir Dis 1993; 148: 1516-1522.
18. Tashkin, D.P., Detels, R., Simmons, M. The UCLA population studies of chronic obstructive pulmonary disease. XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second. Am J Respir Crit Care Med 1994; 149: 1067-1083.
19. American Thoracic Society. Lung function testing: Selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
20. Barberá, J.A., Peces Barba, G., Agustí, A.G.N. y cols. Guía clínica para el diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol (en prensa).
21. Postma, D.S. When can an exacerbation of COPD be treated at home? Lancet 1998; 351: 1827-1828.
22. Chaouat, A., Weitzenblum, E., Kessler, R. y cols. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 1999; 14: 1002-1008.
23. Connors, A.F.J., Dawson, N.V., Thomas, C. Outcomes following acute exacerbations of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996; 154: 959-996.
24. Moya Mir, M.S., Laguna del Estal, P., Salgado Marqués, R., Calabrese Sánchez, S. Infección respiratoria en observación de urgencias. Emergencias 1997; 9: 98-102.
25. Murata, G.H., Gorby, M.S., Chick, T.W., Halperin, A.K. Use of emergency medical services by patients with decompensated obstructive lung disease. Ann Emerg Med 1989; 18: 501-506.
26. Emerman, C.L., Effron, D., Lukens, T.W. Spirometric criteria for hospital admission of patients with acute exacerbation of COPD. Chest 1991; 99: 595-599.
27. Kessler, R., Faller, M., Fourgaut, G., Mennecier, B., Weitzenblum, E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 158-164.
28. Mahler, D.A., Rosiello, R.A., Harver, A., Lentine, T., McGovern, J.F., Daubenspeck, J.A. Comparison of clinical dysnea ratings and psychophysical measurementes of respiratory sensation in obstructive airways disease. Am Rev Respir Dis 1987; 165: 1229-1233.
29. Fagon, J.Y., Chastre, J., Trouillet, J.L. y cols. Characterization of distal bronchial microflora during acute exacerbations of chronic bronchitis: Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990; 142: 1004-1008.
30. Cabello, H., Torres, A., Celts, R. y cols. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: A bronchoscopic study. Eur Respir J 1997; 10: 1137-1144.
31. Ewig, S., Soler, N., Torres, A. Evaluation of antimicrobial treatment in patients with severe exacerbations of chronic pulmonary disease. Clin Pulm Med 1999; 6: 1-8.
32. Heffelfinger, J.D., Dowell, S.F., Jorgensen, J.H. y cols. Management of community acqaired pneumonia in the era of pneumococcal resistance: A report from drug-resistant Streptococcus pneumoniae. Therapeutic Working Group. Arch Int Med 2000; 160: 1339-1408.
33. Rosón, B., Carratalá, J., Verdaguer, R., Dorca, J., Manresa, F., Gudiol, F. Prospective study of the usefulness of Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000; 31: 869-874.
34. Chodosh, S. Bronchitis and asthma. En: Gosbach, S.L., Bartlett, J.G., Blacklow, N.R. (Eds.). Infectious Disease. WB Saunders, Philadelphia 1992; 476-485.
35. Lindsay, G., Scorer, H.J., Carnegie, C.M. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: A randomized, double-blind trial. J Antimicrob Chemother 1992; 13: 89-100.
36. Ball, P., Harris, J.M., Lowson, D. y cols. Acute infective exacerbations of chronic bronchitis. QJM 1995; 88: 61-68.
37. Anzueto, A., Niederman, M.S., Tillotson, G. y cols. Etiology, susceptibility and treatment of acute bacterial exacerbations for complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Clin Ther 1998; 20: 885-890.
38. DeAbate, A.C., Henry, D., Beusch, G. y cols. Sparfloxacin vs ofloxacin in the treatment of acute exacerbations of chronic bronchitis: A multicenter, double-blind, randomized, comparative study. Chest 1998; 114: 120-130.
39. Panckuch, G., Visalli, M.A., Jacobs, M., Appelbaum, P. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. Antimicrob Agents Chemother 1998; 42: 624-630.
40. Baquero, F., García-Rodríguez, J.A., García de Lomas, J., Aguilar, L. The Spanish Surveillance group: Antimicrobial resistance of 1113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1 year (1996-1997) multicenter surveillance study. Antimicrob Agents Chemother 1999; 43: 357-359.
41. McGowan, A., Wootton, M., Holt, A. The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility J Antimicrob Chemother 1999; 43: 345-349.
42. Madaras-Kelly, K., Ostergaard, B., Houde, L.B., Rotschafer, J. Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model. Antimicrob Agents Chemother 1996; 40: 627-632.
43. Bonfiglio, G. Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa? Chemotherapy 2000; 47: 239-242.
44. Yagel, S., Barret, J., Amaratunga, D., Frosco, M. In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia. Antimicrob Agents Chemother 1996; 40: 2894-2897.
45. Ishida, H., Ishida, Y., Kurosaka, Y., Otani, T., Sato, K., Kobayashi, H. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother 1998; 42: 1651-1645.
46. Bouza, E., García-Garrote, F., Cercenado, E., Marín, M., Díaz, M.S. Pseudomonas aeruginosa: A survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group. Antimicrob Agents Chemother 1999; 43: 981-982.
47. May, J.R. The bacteriology of chronic bronchitis. Lancet 1953; 351: 534-537.
48. Pollock, H.M., Hawkins, E.L., Bonner, J.R., Sparkman, T., Bass, J.B.J. Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy. J Clin Microbiol 1983; 17: 255-259.
49. Fagon, J.Y., Chastre, J., Trouillet, J.L. y cols. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990; 142: 1004-1008.
50. Zalacaín, R., Achotegui, V., Pascal, I., Camino, J., Barron, J., Sobradillo, V. El cepillado protegido bacteriológico en pacientes con EPOC severa. Arch Bronconeumol 1997; 33: 16-19.
51. Murphy, T.F. Haemophilus influenzae in chronic bronchitis. Semin Respir Infect 2000; 15: 41-51.
52. Murphy, T.F., Sethi, S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 146: 1067-1083.
53. Lehmann, D., Coakley, K.J., Coaldey, C.A. y cols. Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea. Am Rev Respir Dis 1991; 144: 324-430.
54. Tandon, M.K., Gebski, V. A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis. Aust N Z J Med 1991; 21: 427-432.
55. Clancy, R., Cripps, A., Murree-Allen, K., Yeung, S., Engel, M. Oral immunization with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease. Lancet 1985; ii: 1395-1397.
56. Clancy, R.L., Cripps, A.W., Gebski, V. Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae. Med J Aust 1990; 152: 413-416.
57. Foxwell, A.R., Cripps, A.W. Haemophilus influenzae oral vaccination against acute bronchitis. Cochrane Database Syst Rev 2000; CD001958.
58. Nelson, M.B., Murphy, T.F., van Keulen, H., Rekosh, D., Apicella, M.A. Studies on P6, an important outer-membrane protein antigen of Haemophilus influenzae. Rev Infect Dis 1988; 10 (Suppl. 2): S331-336.
59. Kyd, J.M., Dunkley, M.L., Cripps, A.W. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model. Infect Immun 1995; 63: 2931-2940.
60. Prevention of pneumonococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46: 1-24.
61. Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec 1999; 74: 177-183.
62. Bacle, A., Diot, P., Lemarie, E. Vaccin anti-pneumococcique: Justifications et resultats. Rev Pneumol Clin 1997; 53: 128-137.
63. Gump, D.W., Phillips, C.A., Forsyth, B.R., McIntosh, K., Lamborn, K.R., Stouch, W.H. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976; 113: 465-474.
64. Buscho, R.O., Saxtan, D., Shultz, P.S., Finch, E., Mufson, M.A. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis 1978; 137: 377-383.
65. Smith, C.B., Golden, C.A., Kanner, R.E., Renzetti, A.D.J. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1980; 121: 225-232.
66. Soler, N., Torres, A., Ewig, S. y cols. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157: 1498-1505.
67. Poole, P.J., Chacko, E., Wood-Baker, R.W.B., Cates, C.J. Influenza vaccine for patients with chronic obstructive pulmonary disease (Cochrane review), vol. 1. Cochrane Library, Oxford, Update Software 2001.
68. Ahmed, A.H., Nicholson, K.G., Nguyen-van Tam, J.S., Pearson, J.C. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiol Infect 1997; 118: 27-33.
69. Gross, P., Barret, T., Dellinger, E. y cols. Purpose of quality standards for infectious diseases. Clin Infect Dis 1994; 18: 421.